Johnson & Johnson (NYSE: JNJ) is 12.23% higher on its value in year-to-date trading and has touched a low of $140.68 and a high of $168.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The JNJ stock was last observed hovering at around $159.68 in the last trading session, with the day’s gains setting it 2.62%.
Currently trading at $162.30, the stock is 5.16% and 8.93% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.25 million and changing 1.64% at the moment leaves the stock 5.17% off its SMA200. JNJ registered 2.81% gain for a year compared to 6-month loss of 1.34%.
The stock witnessed a 11.72% gain in the last 1 month and extending the period to 3 months gives it a 4.87%, and is 3.21% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.84% over the week and 1.61% over the month.
Johnson & Johnson (JNJ) has around 138100 employees, a market worth around $390.76B and $88.82B in sales. Current P/E ratio is 28.00 and Fwd P/E is 14.64. Profit margin for the company is 15.84%. Distance from 52-week low is 15.37% and -3.88% from its 52-week high. The company has generated returns on investments over the last 12 months (13.61%).
with sales reaching $21.65B over the same period.The EPS is expected to grow by 6.08% this year, but quarterly earnings will post 1.40% year-over-year. Quarterly sales are estimated to grow 1.26% in year-over-year returns.
Johnson & Johnson (JNJ) Top Institutional Holders
The shares outstanding are 2.41B, and float is at 2.40B with Short Float at 0.78%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 229.04 million shares valued at $33.48 billion. The investor’s holdings represent 9.5109% of the JNJ Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 198.19 million shares valued at $$28.97 billion to account for 8.2297 of the shares outstanding. The other top investors are STATE STREET CORP which holds 133.09 million shares representing 5.5266% and valued at over $19.45 billion, while GEODE CAPITAL MANAGEMENT, LLC holds 2.2881 of the shares totaling 55.1 million with a market value of $8.03 billion.
Johnson & Johnson (JNJ) Insider Activity
The most recent transaction is an insider sale by Schmid Timothy,the company’sEVP, WW Chair, MedTech. SEC filings show that Schmid Timothy sold 403 shares of the company’s common stock on Feb 18 ’25 at a price of $156.15 per share for a total of $62928.0. Following the sale, the insider now owns 15098.0 shares.
Johnson & Johnson disclosed in a document filed with the SEC on Feb 07 ’25 that Wolk Joseph J (Exec VP, CFO) sold a total of 13,015 shares of the company’s common stock. The trade occurred on Feb 07 ’25 and was made at $153.89 per share for $2.0 million. Following the transaction, the insider now directly holds 0.0 shares of the JNJ stock.
Still, SEC filings show that on Feb 07 ’25, Wolk Joseph J (Officer) Proposed Sale 13,015 shares at an average price of $153.89 for $2.0 million. The insider now directly holds shares of Johnson & Johnson (JNJ).
